CTCBIO Inc (060590) — Cash Flow Reinvestment Rate
CTCBIO Inc (060590) has a Cash Flow Reinvestment Rate of 0.04x as of September 2025, reinvesting ₩212.02 Million (capex ₩212.02 Million ) from operating cash flow of ₩5.64 Billion. See CTCBIO Inc (060590) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
CTCBIO Inc Cash Flow Reinvestment Rate (2013–2024)
Historical reinvestment intensity for CTCBIO Inc across 10 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of CTCBIO Inc.
Annual Cash Flow Reinvestment Rate for CTCBIO Inc (2013–2024)
Year-by-year capital reinvestment analysis for CTCBIO Inc. See how financially flexible is CTCBIO Inc to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 1.19x | ₩5.36 Billion | ₩4.50 Billion | ₩2.14 Billion | ▲ +176.9% |
| 2023 | 0.43x | ₩3.54 Billion | ₩8.22 Billion | ₩1.88 Billion | ▲ +111.7% |
| 2022 | 0.20x | ₩3.71 Billion | ₩18.22 Billion | ₩3.17 Billion | ▼ -83.4% |
| 2021 | 1.22x | ₩7.89 Billion | ₩6.46 Billion | ₩1.67 Billion | ▼ -80.3% |
| 2020 | 6.22x | ₩3.17 Billion | ₩510.09 Million | ₩1.92 Billion | ▼ -39.6% |
| 2019 | 10.30x | ₩17.25 Billion | ₩1.68 Billion | ₩2.22 Billion | ▼ -25.8% |
| 2017 | 13.87x | ₩4.10 Billion | ₩295.30 Million | ₩3.90 Billion | ▲ +425.2% |
| 2016 | 2.64x | ₩18.12 Billion | ₩6.86 Billion | ₩13.46 Billion | ▼ -85.6% |
| 2015 | 18.35x | ₩26.37 Billion | ₩1.44 Billion | ₩23.71 Billion | ▲ +731.6% |
| 2013 | 2.21x | ₩6.05 Billion | ₩2.74 Billion | ₩6.05 Billion | — |